// App-Quantinova.ai

P138 : Inequity in Clinical Commissioning Group funding across England for high-cost biologic drugs in rheumatoid arthritis

Researchers

Presenter

  • Olivia Buckeldee

Principal Investigators

  • Rajakshi Khanna

  • Laura Snell

  • Laura Attipoe

Medical Centers

  • Kings College London Medical School, London, United Kingdom

  • Fetal Medicine, Whittington Hospital, London, United Kingdom

  • Rheumatology, Guy's Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Abatacept

  • golimumab

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final